Search Results 371-380 of 16354 for Cystinosis%2Bagents

  1. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate microbiota suspension of intestinal microbes. Patients who have had at least one recurrence of Clostridium Difficile ...

  2. Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

    Navitoclax and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility.

  3. A Study of the Presence of Follicular T Cells in the Peripheral Blood of People with Nasal Allergies to Ragweed - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. In Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the effectiveness and safety of Lubiprostone in pediatric patients, aged ≥ 6 years to < 18 years, diagnosed with ...

  5. Vaginal Bromocriptine for Treatment of Adenomyosis - Mayo Clinic

    About this study. Adenomyosis is a rare non-malignant disease of the uterus that causes significant symptoms including heavy menstrual bleeding and pelvic ...

  6. Fig. 1: E-cadherin loss and p120 overexpression in a case of clear renal cell carcinoma (cRCC). Normal tissue is shown in the top and tumor in the bottom ...

  7. A Study Of The Effect Of Ixazomib On The Reservoir Of T Cells Infected With HIV DNA - Mayo Clinic

    The purpose of this study is to determine the safety and tolerability of ixazomib in HIV infected patients who are on a stable regimen of ART that suppresses ...

  8. Cardiac rehabilitation: Revitalizing hearts and lives - Mayo Clinic

    Carmen Terzic, M.D., Ph.D. Chair, Physical Medicine and Rehabilitation · Carol Eggert Patient.

  9. Endocrinology - Doctors - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  10. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...